Profound Medical Corp PROF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $5.80
- Day Range
- $5.66–5.98
- 52-Week Range
- $4.80–8.95
- Bid/Ask
- $4.07 / $7.12
- Shares Outstanding
- 36.54M
- Market Cap
- $213.76M
- Volume/Avg
- 156,426 / 118,075
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 10.23
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 162
- Website
- https://www.profoundmedical.com
Valuation
|
Metric
|
PROF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.29 |
Price/Sales | 10.23 |
Price/Cash Flow | — |
Price/Earnings
PROF
Financial Strength
|
Metric
|
PROF
|
|---|---|
Quick Ratio | 5.25 |
Current Ratio | 6.46 |
Interest Coverage | — |
Quick Ratio
PROF
Profitability
|
Metric
|
PROF
|
|---|---|
Return on Assets (Normalized) | −46.71% |
Return on Equity (Normalized) | −57.71% |
Return on Invested Capital (Normalized) | −53.16% |
Return on Assets
PROF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|rPkmrYP | LOCK|WXgxt | $167B | |||
| Medtronic PLC
MDT
| LOCK|?fB!<%B | LOCK|w>&nj | $111B | |||
| Stryker Corp
SYK
| LOCK|t%h!w^@$ | LOCK|g> | $105B | |||
| Boston Scientific Corp
BSX
| LOCK|lTQlB@? | LOCK|<x>W | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|#>?dM&xl | LOCK|mlDX$ | $49B | |||
| DexCom Inc
DXCM
| LOCK|h@DxG?P | LOCK|jzp! | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|c&RQ@S< | LOCK|%^ | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|NM | LOCK|dLC | $23B | |||
| Steris PLC
STE
| LOCK|@>%x#gP | LOCK|&%^T | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|x^Q@?>gs | LOCK|<>? | $17B |
United States